
51 - 200 employees
Founded 2004
🧬 Biotechnology
💊 Pharmaceuticals
💰 $75M Post IPO equity on 2024-02
Biotechnology • Pharmaceuticals
Liquidia is a biopharmaceutical company focused on developing inhaled therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company leverages its proprietary PRINT® particle engineering technology to create proprietary formulations and delivery methods aimed at improving efficacy, tolerability, and convenience of inhaled medicines; its pipeline includes inhaled treprostinil (commercial product) and clinical-stage candidates such as L606. Liquidia emphasizes patient support, clinical development, and advancing therapies for improved respiratory outcomes.
🔥 22 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2004
🧬 Biotechnology
💊 Pharmaceuticals
💰 $75M Post IPO equity on 2024-02
Biotechnology • Pharmaceuticals
Liquidia is a biopharmaceutical company focused on developing inhaled therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company leverages its proprietary PRINT® particle engineering technology to create proprietary formulations and delivery methods aimed at improving efficacy, tolerability, and convenience of inhaled medicines; its pipeline includes inhaled treprostinil (commercial product) and clinical-stage candidates such as L606. Liquidia emphasizes patient support, clinical development, and advancing therapies for improved respiratory outcomes.
• Direct Commercial new product planning and lifecycle strategy. Provide input into future product development, specifically L606 BID Treprostinil. Integrate global market insights, financial opportunity, and portfolio strategy to optimize future commercial opportunity • Shape upstream clinical development strategy for Phase III and IV studies. Translate unmet needs and financial value into endpoint/label discussions, patient population strategy, and evidence-generation plans to maximize future label strength and access potential • Participate in the annual Brand Planning process for Yutrepia, establishing positioning, core messaging, and strategic objectives across HCP, patient, and payer stakeholders • Track market intelligence for the PH landscape, monitoring market volume and share trends, competitor pipelines. Synthesize insights into decision-ready recommendations • Perform market research to support brand planning, new product planning, and input into clinical development • Act as the commercial voice on cross-functional product teams for programs in development. Integrate with Medical Affairs, Regulatory, Market Access, Commercial Analytics, Finance, and Business Development
• Education and Experience • - Bachelor’s degree required in Marketing, Business, Life Sciences, or a related field • - 10+ years of progressive experience in pharmaceutical or biotechnology commercial roles • - Significant experience in strategic marketing, commercial strategy, brand management, and/or new product planning • - Experience in rare disease, especially Pulmonary Hypertension, is a plus • Knowledge, Skills, and Abilities • - Deep understanding of pharmaceutical commercialization, including brand strategy, lifecycle management, new product planning • - Strong understanding of clinical development processes, evidence-generation strategies, labeling considerations, and regulatory pathways. • - Analytical and insights capabilities—proficiency in interpreting qualitative and quantitative market research, competitive intelligence, and performance analytics • - Financial acumen—comfort with forecasting models, scenario planning, and business case development for lifecycle or pipeline investments • - Ability to thrive in small company environment
• Liquidia offers a competitive compensation package as well as a comprehensive benefits package that includes Medical, Dental, Vision, STD, LTD, 401(k) Savings Retirement Plan, ESPP, and more!
Apply Now🔥 42 minutes ago
Director of FedRAMP Strategy at Excentium, leading market development and federal relationships for cybersecurity. Elevating Excentium's presence within the FedRAMP community.
🔥 1 hour ago
Director of Higher Education Strategy & Implementation providing strategic leadership for Immigrants Rising’s higher education portfolio. Bridging direct services, partnerships, and engagement to advance undocumented students' educational access.
🇺🇸 United States – Remote
💵 $100k - $103.7k / year
💰 $20k Grant - Immigrants Rising on 2024-07
⏰ Full Time
🔴 Lead
🧐 Strategy
🔥 1 hour ago
Vice President, Engagement Strategy leading healthcare brand engagement through integrated strategies. Collaborating with teams to drive innovation, AI utilization, and personalized customer experiences.
🔥 1 hour ago
Strategy Director leading the development and execution of marketing strategies for diverse clients at 829 Studios. Innovating marketing solutions with data-driven insights and multichannel marketing expertise.
🇺🇸 United States – Remote
💵 $115k - $135k / year
💰 Series unknown on 2021-09
⏰ Full Time
🔴 Lead
🧐 Strategy
🔥 1 hour ago
Group Strategy Director at 829 Studios managing strategic client engagements and leading a team of strategists. Overseeing resource allocation, strategic processes, and client relationships to drive success.